Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Baiyunshan Pharmaceutical Holdings's GHG Emissions Data Preview
In 2024, Baiyunshan Pharmaceutical Holdings completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Baiyunshan Pharmaceutical Holdings has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Scope 1 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 2 | ||||
Unspecified Calculation Method | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Total Scope 3 | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Scope 1 Revenue Intensity (tCO2e/$M) | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | Copy restricted. Please purchase to unlock this data.  a | 0000000 |
Verified Sources Behind Baiyunshan Pharmaceutical Holdings’s Greenhouse Gas (GHG) Emissions Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Baiyunshan Pharmaceutical Holdings’s data sources below and access millions more through our Disclosure Search.
Insights into Baiyunshan Pharmaceutical Holdings's Operational Emissions
In 2024, the total operational greenhouse gas (GHG) emissions of Baiyunshan Pharmaceutical Holdings amounted to 171,373.83 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a
Compared to 2023, the total operational greenhouse gas (GHG) emissions of Baiyunshan Pharmaceutical Holdings decreased by 41.87%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a
Baiyunshan Pharmaceutical Holdings's Scope 1 Emissions Over Time
- Total Scope 1
- Year-over-Year Change
What are Baiyunshan Pharmaceutical Holdings's Scope 1 emissions?
In 2024, the total Scope 1 emissions of Baiyunshan Pharmaceutical Holdings were 34,042.94 metric tons of CO₂ equivalent (tCO₂e). a
Has Baiyunshan Pharmaceutical Holdings reduced its Scope 1 emissions over time?
Since 2021, Baiyunshan Pharmaceutical Holdings's Scope 1 emissions have decreased by 4.14%, reflecting a declining long-term trend in Scope 1 emissions over time. a b
Compared to the previous year (2023), Baiyunshan Pharmaceutical Holdings's Scope 1 emissions decreased by 80.15%, highlighting the company's efforts to lower direct emissions from assets it owns or controls. a
What are Baiyunshan Pharmaceutical Holdings's Scope 2 emissions?
In 2024, Baiyunshan Pharmaceutical Holdings reported Scope 2 greenhouse gas (GHG) emissions of 137,330.89 tCO₂e without specifying the calculation method. a
Has Baiyunshan Pharmaceutical Holdings reduced its Scope 2 emissions over time?
Since 2021, Baiyunshan Pharmaceutical Holdings's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 54.83%, reflecting a rising long-term trend in Scope 2 emissions over time. a b
Compared to the previous year (2023), Baiyunshan Pharmaceutical Holdings's Scope 2 emissions (Unspecified Calculation Method) rose by 11.35% in 2024, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a
What methodology does Baiyunshan Pharmaceutical Holdings use for Scope 2 reporting?
In 2024, Baiyunshan Pharmaceutical Holdings reported its Scope 2 emissions using an unspecified methodology. a
Baiyunshan Pharmaceutical Holdings's Scope 2 Emissions Over Time
- Total Scope 2 (Unspecified Calculation Method)
Insights into Baiyunshan Pharmaceutical Holdings's Value Chain Emissions
In 2024, Baiyunshan Pharmaceutical Holdings reported 430,312 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a
The 2024 disclosure of Baiyunshan Pharmaceutical Holdings includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2023, demonstrating consistent Scope 3 emissions reporting coverage year over year. a
Baiyunshan Pharmaceutical Holdings's Scope 3 Emissions Over Time
- Total Scope 3
- Year-over-Year Change
What are Baiyunshan Pharmaceutical Holdings's Scope 3 emissions?
In 2024, Baiyunshan Pharmaceutical Holdings reported total Scope 3 emissions of 430,312 metric tons of CO₂ equivalent (tCO₂e). a
Compared to the previous year (2023), Baiyunshan Pharmaceutical Holdings's Scope 3 emissions increased by 2,424.98%, suggesting that the company faced challenges in reducing emissions across its value chain. a
Insights into Baiyunshan Pharmaceutical Holdings’s GHG Emissions Intensity Compared to Industry Peers
In 2024, Baiyunshan Pharmaceutical Holdings reported Scope 1 greenhouse gas (GHG) emissions of 34,042.94 tCO₂e and total revenues of USD 10,276 millions. This translates into an emissions intensity of 3.31 tCO₂e per millions USD. a
Baiyunshan Pharmaceutical Holdings's Scope 1 Emissions Intensity Compared to Peers
How does Baiyunshan Pharmaceutical Holdings's GHG emissions intensity compare to its peers?
In 2024, Baiyunshan Pharmaceutical Holdings reported a Scope 1 emissions intensity of 3.31 tCO₂e per millions USD. Compared to the peer group median of 11.06 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a
Where does Baiyunshan Pharmaceutical Holdings rank on GHG emissions intensity within its industry?
In 2024, Baiyunshan Pharmaceutical Holdings ranked 9 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a
Baiyunshan Pharmaceutical Holdings is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a
Insights into Baiyunshan Pharmaceutical Holdings's Total Carbon Footprint
In 2024, Baiyunshan Pharmaceutical Holdings reported a total carbon footprint of 601,685.83 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 92.95% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a
The largest contributor to Baiyunshan Pharmaceutical Holdings's total carbon footprint was Scope 3 emissions, accounting for 71.52% of the company's total carbon footprint, followed by Scope 2 emissions at 22.82%. a